Olink Holding AB (publ) (OLK)
26.08
0.08 (0.31%)
At close: Jul 09, 2024, 8:00 PM
0.31% (1D)
| Bid | n/a |
| Market Cap | 3.24B |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| EPS (ttm) | -0.27 |
| PE Ratio (ttm) | -96.5925925925926 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | n/a |
| Volume | 1,885,999 |
| Avg. Volume (20D) | 545,957 |
| Open | 26.00 |
| Previous Close | 26.00 |
| Day's Range | 25.98 - 26.08 |
| 52-Week Range | 14.10 - 26.09 |
| Beta | 0.52 |
About OLK
Olink Holding AB (publ) provides various products and services for the academic, government, biopharmaceutical, biotechnology, and other institutions that focuses on life science research. Its products include Olink Explore for cardiovascular and metabolic, oncology, neurology, or inflammation diseases; Olink Target product line; and Olink Focus product line that consists of custom developed solutions for customers that has identified various pro...
Industry Medical - Diagnostics & Research
Sector Healthcare
IPO Date Mar 26, 2021
Employees 707
Stock Exchange NASDAQ
Ticker Symbol OLK
Website https://www.olink.com
